This is a StreetInsider.com Premium Only Page

(PLRX) – StreetInsider.com Reports

Mar 12, 2024 07:30 AM Pliant Therapeutics Inc. (PLRX) Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis

Mar 5, 2024 08:46 AM Pliant Therapeutics (PLRX) PT Raised to $54 at RBC Capital

Feb 28, 2024 06:13 AM Pliant Therapeutics (PLRX) PT Lowered to $50 at RBC Capital

Feb 8, 2024 07:16 AM Pliant Therapeutics (PLRX) PT Lowered to $43 at Canaccord Genuity

Feb 6, 2024 05:36 AM Pliant Therapeutics (PLRX) PT Lowered to $47 at Oppenheimer

Feb 5, 2024 11:38 AM Pliant Therapeutics (PLRX) PT Lowered to $33 at BTIG

Feb 5, 2024 06:38 AM Pliant Therapeutics (PLRX) PT Lowered to $48 at H.C. Wainwright

Feb 5, 2024 05:50 AM Pliant Therapeutics (PLRX) Reports Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast

Dec 7, 2023 04:26 PM Wells Fargo Starts Pliant Therapeutics (PLRX) at Overweight

Nov 10, 2023 07:55 AM Pliant Therapeutics (PLRX) PT Lowered to $34 at Stifel

Nov 10, 2023 07:54 AM Pliant Therapeutics (PLRX) PT Lowered to $47 at JPMorgan

Nov 10, 2023 06:54 AM Pliant Therapeutics (PLRX) PT Lowered to $53 at RBC Capital

Nov 10, 2023 04:24 AM Pliant Therapeutics (PLRX) PT Lowered to $49 at Oppenheimer

Nov 9, 2023 05:36 PM Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 8c

Oct 9, 2023 08:54 AM Piper Sandler highlights 12 biotech takeover targets as M&A 'about as conducive as we've seen'

Sep 27, 2023 06:06 AM Pliant Therapeutics (PLRX) PT Raised to $52 at H.C. Wainwright

Sep 26, 2023 07:48 AM Pliant Therapeutics (PLRX) Climbs 27% Following Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Trial of Bexotegrast

Sep 26, 2023 07:30 AM Pliant Therapeutics (PLRX) Reports Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Trial of Bexotegrast

Sep 25, 2023 05:20 PM After-hours movers: Pliant Therapeutics gains ahead of data, Coty falls on offering

Sep 15, 2023 08:01 AM Pliant Therapeutics (PLRX) Appoints Minnie Kuo as Chief Development Officer

Aug 10, 2023 07:37 AM Pliant Therapeutics (PLRX) PT Raised to $52 at Oppenheimer

Aug 10, 2023 06:58 AM Pliant Therapeutics (PLRX) PT Raised to $48 at JPMorgan

Aug 10, 2023 06:13 AM Pliant Therapeutics (PLRX) PT Lowered to $54 at RBC Capital

Aug 9, 2023 05:55 PM Pliant Therapeutics, Inc. (PLRX) Tops Q2 EPS by 1c

May 24, 2023 08:04 AM Pliant Therapeutics Inc. (PLRX) Presents Data from Bexotegrast Program

May 18, 2023 05:23 AM Canaccord Genuity Starts Pliant Therapeutics (PLRX) at Buy

May 11, 2023 06:36 AM Pliant Therapeutics (PLRX) PT Lowered to $50 at H.C. Wainwright

May 10, 2023 08:12 AM Pliant Therapeutics (PLRX) PT Raised to $51 at Oppenheimer

May 10, 2023 06:23 AM Pliant Therapeutics (PLRX) PT Lowered to $57 at RBC Capital

May 9, 2023 06:04 PM Pliant Therapeutics, Inc. (PLRX) Reports In-Line Q1 EPS

May 1, 2023 06:39 AM Pliant Therapeutics (PLRX) PT Raised to $55 at H.C. Wainwright

May 1, 2023 06:37 AM Pliant Therapeutics (PLRX) PT Raised to $63 at Cantor Fitzgerald

May 1, 2023 05:22 AM Pliant Therapeutics Inc. (PLRX) Reports Positive Long-Term Data from the INTEGRIS-IPF Phase 2a Trial

Apr 13, 2023 06:37 AM Baird Starts Pliant Therapeutics (PLRX) at Outperform, 'We believe there's currently little priced in the stock'

Mar 27, 2023 04:08 PM Pliant Therapeutics Inc. (PLRX) Files Mixed Shelf

Mar 20, 2023 06:39 AM Pliant Therapeutics (PLRX) PT Raised to $54 at H.C. Wainwright

Mar 13, 2023 08:02 AM Pliant Therapeutics (PLRX) Announces Positive DSMB Safety Review and Initiation of Enrollment of Phase 2a Trial of Bexotegrast

Mar 10, 2023 07:39 AM Pliant Therapeutics (PLRX) PT Raised to $44 at Oppenheimer

Mar 10, 2023 06:43 AM Pliant Therapeutics (PLRX) PT Lowered to $50 at Citi

Feb 2, 2023 08:03 AM Pliant Therapeutics Inc. (PLRX) Announces FDA Clearance of IND for PLN-101095

Jan 25, 2023 05:42 AM Pliant Therapeutics Inc. (PLRX) Prices Upsized 8.33M Share Offering at $30/sh

Jan 24, 2023 02:21 AM Pliant Therapeutics (PLRX) PT Raised to $55 at Citi

Jan 23, 2023 05:51 PM After-hours movers: HighPeak Energy jumps on strategic review

Jan 23, 2023 04:02 PM Pliant Therapeutics Inc. (PLRX) Announces $175M Proposed Public Offering of Common Stock

Jan 23, 2023 11:12 AM Pliant Therapeutics (PLRX) PT Raised to $45 at Stifel following data

Jan 23, 2023 07:06 AM Pliant Therapeutics (PLRX) Climbs 80% After Positive Data from INTEGRIS-IPF Phase 2a Trial of Bexotegrast

Jan 23, 2023 05:44 AM Pliant Therapeutics Inc. (PLRX) Reports Positive Data from INTEGRIS-IPF Phase 2a Trial of Bexotegrast

Dec 15, 2022 08:08 AM Pliant Therapeutics (PLRX) Receives Orphan Designation from the European Medicines Agency for Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary Fibrosis

Dec 13, 2022 05:16 PM Today's most important initiations

Dec 13, 2022 04:07 PM Stifel Starts Pliant Therapeutics (PLRX) at Buy